USO - Oncology Hematology Care

Cincinnati, Ohio 45242

1 studies enrolling now · 3 studies all time

What they study most

Acute Myeloid Leukemia (AML), Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Higher-Risk Myelodysplastic Syndrome (HR-MDS), Metastatic Castration-Resistant Prostate Cancer (mCRPC), Metastatic Colorectal Cancer (mCRC), Neoplasm Metastasis, Newly Diagnosed Intermediate/High-Risk MDS, Relapsed/Refractory Multiple Myeloma (RRMM)

Studies at this site

• A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer — Recruiting now
• A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer — Running, not enrolling
• Study of the Safety, Tolerability and Efficacy of KPT-8602 in Participants With Relapsed/Refractory Cancer Indications — Completed